NewAmsterdam Pharma Company
NAMS
#4536
Rank
S$3.11 B
Marketcap
S$25.96
Share price
0.85%
Change (1 day)
-48.15%
Change (1 year)

EPS for NewAmsterdam Pharma Company (NAMS)

EPS in 2026 (TTM): S-$2.15

According to NewAmsterdam Pharma Company's latest financial reports the company's current EPS (TTM) is S-$2.15. In 2025 the company made an earnings per share (EPS) of S-$2.22 an increase over its 2024 EPS that were of S-$3.30.

EPS history for NewAmsterdam Pharma Company from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.15-2.91%
2025S-$2.22-32.81%
2024S-$3.3019.07%
2023S-$2.7780.67%
2022S-$1.53132.27%
2021S-$0.66490.94%
2020S-$0.11